Thursday, 5 September 2019

Urology Devices Market Expected to Grow At A Significant Rate During The Forecast Period


Urology Devices Market Overview:
Market Research Future (MRFR) in their latest report on the global urology devices market revealed that a 7.1% CAGR during the forecast period (2017-2023) is possible if factors play right throughout. The urology devices market can even surpass its expected market worth by the end of 2023. Urology is the branch of medical studies that focuses on female urinary tract system and the male reproductive organs. Organs that are part of this study includes kidneys, adrenal glands, ureters, urinary bladder, urethra, and the male reproductive organs. Devices related to the study of this field is getting significant traction owing to the prevalence of diseases that affect these organs. Along with it, advents in technology is something that can guide the market forward.
However, the urology devices market can get pulled back due to the poor reimbursement policies and costly devices. But the urology devices market can benefit from the rivalry taking place between companies for better market percolation.  
Segmentation:
MRFR in their detailed discussion on the global urology devices market put a special emphasis on the segments. These segments are types, applications, technology, and end-users.
Based on the types, the urology devices market can be segmented by urinary stone treatment devices, dialysis equipment, benign prostatic hyperplasia treatment devices, endoscopy devices, urinary incontinence & pelvic organ prolapsed devices, and others. The dialysis equipment segment can be further segmented into haemodialysis, peritoneal dialysis, and others. The urinary stone treatment devices segment includes lithotripsy, ureteral stents, and others. The urinary incontinence & pelvic organ prolapsed devices segment consists urethral inserts & pessaries, vaginal meshes & slings, sacral neuromodulator, and others. The benign prostatic hyperplasia treatment devices segment includes catheter ablation, prostatic stents, and others. The dialysis segment has substantial market presence and it can grow bigger during the forecast period.
Based on the technology, the urology devices market can be segmented into robotic surgery, minimally invasive surgery, and others. The robotic surgery segment is all set to expand with substantial market domination.
Based on the applications, the urology devices market includes urinary incontinence, prostate cancer, urinary stones, benign prostatic hyperplasia, and others.
With the focus on end-users, the urology devices market can be segmented into hospitals, ambulatory services and others. The hospitals segment can expect for substantial market expansion.
Regional Analysis:
MRFR, in their region-specific analysis of the global urology devices market, includes the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).
The Americas has the maximum market share owing to the significant technological advancement they have made in their field. The region has high healthcare expenditure and the cases related to kidney are quite prevalent owing to which the sector can expect substantial rise.
Europe is only second to the Americas in terms of generating revenues for the market. The region has the strength to retain its global position during the forecast period with significant market possession. Europe’s increasing investment in the research & development is one strong point that is going to set their future market demography on the track of profit.
The APAC market is quite lucrative as several countries from the region are experiencing strong economic surge. High healthcare expenditure can be witnessed as well as governments are spending heavily to revamp their healthcare infrastructure. Riding on such developments the regional market is expected to grow with the fastest CAGR during the forecast period.
Competitive Landscape:
Players to substantially influence the global urology devices market are Olympus Corporation (Japan), KARL STORZ GmbH & Co. KG (Germany), Boston Scientific Corporation (US), Medtronic (US), C. R. Bard, Inc. (US), Stryker (US), HealthTronics, Inc (US), NIKKISO CO. LTD (Japan), Fresenius Medical Care AG & Co. KGaA (Germany), Cook (US), Dornier MedTech (Germany), and others.
In 2018, Urotronic, a startup based out of Plymouth raised USD 20 million in Series B funding led by HM (Hillhouse & Mayo Clinic) Ventures. Among other significant investors CDBI Partners, OCXPROURO Limited andLegend Capital are crucial. The investment is to support a new product called Optilume that can keep the urinary tract clear.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Posted by at 1 comment:
Labels: , ,

Monday, 2 September 2019

Odontogenic Tumor Market size share global industry research key companies review forecast to 2023

Odontogenic Tumor Market - Highlights
The Odontogenic Tumor is the abnormal growth of cells in and around the jaws and teeth. Many of these tumors are considered to be benign. In usual cases, odontogenic tumors are malignant means they are likely to spread in jaws and teeth. 
This tumor can be diagnosed using different techniques such as computerized tomography scan (also called a CT or CAT scan), magnetic resonance imaging (MRI), and biopsy. The increasing incidence of the odontogenic tumor and other dental-related diseases, rising geriatric population, and increasing incidence of children suffering from an odontogenic tumor and dental clinics are anticipated to drive the growth of the market during the forecast period.
However, unfavorable reimbursement scenario and lack of awareness among the people regarding odontogenic tumor may hamper the growth of the market during the assessment period. The global odontogenic tumor market is dominated by many market players. The key players in the market are engaged in new launches and strategic collaborations to hold their market position. 
Leading Key Players
Some of the key players in the global odontogenic tumor market are Midwest dental Inc, Burkhart Dental Supply Co., Inc, Delta Dental Plans Association, Patterson Dental Supply, Inc, DeCare Dental, LLC, Oral Cancer Prevention International, Inc, Zila, Inc, Altima Dental Canada, Inc, OraTec Corporation, Oral health innovation Ltd, Senior Dental Care, LLC, and Amerident Dental Inc.
Odontogenic Tumor Market - Segmentation
The global odontogenic tumor market is segmented into types of tumor, diagnosis, treatment, and end-user. Based on types of tumor the odontogenic tumor market is segmented into two segments, namely, malignant odontogenic tumors and benign odontogenic tumors.
Malignant odontogenic tumors are further sub-segmented into ameloblastic carcinoma, primary intraosseous carcinoma, NOS sclerosing odontogenic carcinoma, clear cell odontogenic carcinoma, ghost cell odontogenic carcinoma, odontogenic carcinosarcoma, and odontogenic sarcomas.
Benign odontogenic tumors are further segmented into epithelial origin, mixed (Epithelial-Mesenchymal) origin, and mesenchymal origin. Epithelial origin is further sub-segmented into ameloblastoma, conventional, squamous odontogenic tumor, calcifying epithelial odontogenic tumor, and adenomatoid odontogenic tumor.
Mixed (Epithelial-Mesenchymal) origin is further sub-segmented into ameloblastic fibroma, primordial odontogenic tumor, odontoma, and dentinogenic ghost cell tumor. Mesenchymal origin is further sub-segmented into odontogenic fibroma, odontogenic myxoma/myxofibroma, cementoblastoma, and cemento-ossifying fibroma.
On the basis of diagnosis, the odontogenic tumor market is further segmented into computerized tomography scan (also called a CT or CAT scan), magnetic resonance imaging (MRI), and biopsy. Based on treatment, the odontogenic tumor market is further segmented into surgery, radiation therapy, and chemotherapy.
Based on end-user, the odontogenic tumor market is further segmented into hospitals, dental clinics, dental laboratories, dental academics, and research institutes.
Detailed Regional Analysis
The market in the Americas is expected to dominate the global odontogenic market during the forecast period owing to the increasing prevalence of odontogenic tumor diseases along with the growing geriatric population and well-established healthcare sector in the region.
The European market is expected to be the second-largest due to government funding and support from the healthcare sector, coupled with increasing research and development. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing market during the forecast period owing to technological developments, an increasing number of advanced surgeries in emerging economies, and favorable government initiatives for healthcare facilities.
The Middle East and Africa is anticipated to hold the smallest share of the global odontogenic tumor market. The market growth in this region can be attributed to the increasing healthcare expenditure and lack of awareness among the people regarding odontogenic tumor in children.
About Us:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312

Posted by at No comments:
Labels: , ,

Global Prostate Cancer Market: What it got next? Find out with the latest research available at 'The Market Reports'

Overivew
The Global Prostate Cancer Market is expected to grow with a CAGR of approximately 10.5% during the forecast period from 2017-2027. prostate cancer is a disease of the prostate gland. These glands are responsible for the production and secretion of prostate fluid as a component of semen in addition to that it also acts as a regulator of urine control in men.
International Prostate Cancer Market Business Overview:
As per a survey conducted by the American Cancer Society, about 1 in 7 men are estimated to be diagnosed with prostate cancer during their lifetime. Moreover, according to a UK based government institute namely Cancer Research Organization estimated that nearly 46,690 new cases of prostate cancer were diagnosed in 2014 with a death toll of 11,287 patients. Furthermore, there are various initiatives undertaken by key players to collaborate with government organization to spread awareness regarding the clinical symptoms of prostate cancer. Moreover, the promotion of diagnostic & screening tests for early detection such as Digital Rectal Exam (DRE), and Prostate-Specific Antigen (PSA). In addition, major players including Dendreon Corporation, Sanofi, AstraZeneca Plc, Johnson & Johnson Inc., and Astellas Pharms, Inc., are aiming to develop safe and effective therapeutic products to treat tumor.
Besides, blockbuster drugs such as Zytiga, Taxotere, Xtandi, Eligard, Xofigo, and Provenge, holding a robust position in the global prostate cancer market. Johnson & Johnson’s brand Zytiga is considered as a gold standard for the treatment of prostate cancer. Rise in the funding in both private and public sector for the drug development, technological advancements in finding new techniques to fight prostate cancer,  lifestyle changes, are few factors driving the growth of the market. Side effects of surgery such as urinary impotence & incontinence and surgical risks such as blood clots, stroke, and heart attack are certain constraints encountered by the global prostate cancer market.
Prostate Cancer Market Top Key Players Overview:
OncoGenex Pharmaceuticals Inc., Bayer Pharma AG (Germany), Progenics Pharmaceuticals, Inc. (US), TOLMAR Inc. (US), OncBioMune Pharmaceuticals Inc. (US), Endo Pharmaceuticals Inc. (US), Tokai Pharmaceuticals Inc. (US),  Active Biotech (US), ADC Therapeutics (US), Advantagene (US), Advaxis Pharmaceuticals (US), ANI Pharmaceuticals (US), ArQule (US), Athenex Pharmaceuticals (US), Bavarian Nordic (US), BHR Pharma (US), Boehringer Ingelheim (Germany), Cleveland BioLabs (US), Dextech Medical (US), Eisai (US), Endo Pharmaceuticals (US), Ferring Pharmaceutical (US), GTx (US), Innocrin Pharmaceutical (US), Inspyr Therapeutics (US), Io Therapeutics (US), Lidds AB (US), Merck Group (US), Myovant Sciences (US), Northwest Biotherapeutics (US), Novartis AG (Switerzland), Nymox Pharmaceuticals (US), OncoGenex (US), Oncolytics Biotech (US), Orion (US), CureVac (US), Pharmamar (US), Camurus (US), Foresee Pharmaceuticals (US), Progenics Pharmaceuticals (US), Sotio (US), Spectrum Pharmaceuticals (US), Synta (US), Takeda Pharmaceuticals (Japan), Teva Pharmaceutical (Israel), Tokai Pharmaceuticals (US), AbbVie (US),  Astellas Pharma (Japan), AstraZeneca (US), Johnson & Johnson (US), Sanofi (France), Ipsen (US), Valeant Pharmaceuticals (US), Dendreon Corporation (US), and others are some of the prominent players at the forefront of competition in the global prostate cancer market and are profiled in MRFR Analysis.
Industry Updates
March, 2018 Astellas pharma received FDA approval for Xtandi tablets, a treatment for castration-resistant prostate cancer, in Japan
Jan, 2015 Janssen Pharmaceutical Companies r received FDA approval for Zytiga (abiraterone acetate) for the treatment of prostate cancer
Global Prostate Cancer Market - Regional Analysis:
The global prostate cancer market is segmented into five major regions including Americas, Europe, Asia Pacific, and Middle East and Africa region.
Americas dominated the global prostate cancer market in terms of revenue share owing to the increasing R&D in the region and presence of big outsourcing firms. In the U.S., it is the most common cancer in men, but it is also treatable if found in the early stages. Prostate Cancer Foundation of Canada supports research, cure, and prevention of prostate cancer via online portal. According to the American Cancer Society in 2017 expected that about 161,360 new cases of prostate cancer will be diagnoses, and that around 26,730 fatalities will occur because of it.
The European market is the second largest market for prostate cancer plays an important role to minimize the cost of clinical trials. Furthermore, Asia Pacific region has emerged as the fastest growing market for prostate cancer.
The Middle-East and Africa prostate cancer market has been evaluated as moderately growing market and it is expected that the market will continue to grow at same pace in the near future.
Table of Contents
1 INTRODUCTION
1.1 DEFINITION
1.2 SCOPE OF STUDY
1.2.1 RESEARCH OBJECTIVE
1.2.2 ASSUMPTIONS & LIMITATIONS
1.2.2.1 ASSUMPTIONS
1.2.2.2 LIMITATIONS
1.3 MARKET STRUCTURE:
2 RESEARCH METHODOLOGY
2.1 RESEARCH PROCESS:
2.2 PRIMARY RESEARCH
2.3 SECONDARY RESEARCH:
3 MARKET DYNAMICS
3.1 DRIVERS
3.2 RESTRAINTS
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: , , , ,

Friday, 30 August 2019

Assisted Reproductive Technology (ART) Market size, Share, Analysis, Global Industry Demand By 2023

Assisted reproductive technology (ART) market is gaining precedence owing to its ability to cure women having infertility issues. The assisted reproductive technology industry includes fertility medication, in vitro fertilization and surrogacy. The global assisted reproductive technology market can experience a 10% CAGR during the forecast period (2018-2023), reveals Market Research Future (MRFR) in a report that covers drivers of the said market and segments in detail. Infertility cases are on the rise, that too, at an alarming rate. This has been triggered by a sedentary lifestyle, obesity, ovulation disorder, unhealthy diet, increasing intake of tobacco & alcohol, and chronic diseases.
Get Free Sample PDF Copy Of Global Assisted Reproductive Technology Market Research Report!!https://www.marketresearchfuture.com/sample_request/6359
Assisted reproductive technology includes fertility medication, in vitro fertilization, and other processes used to counter infertility in women and men and bring about fertilization. Causes of infertility among women may range from ovulation disorders and uterine or cervical abnormalities to cancer and endometriosis. Lifestyle factors such as excessive smoking and obesity also play a part in the causation of infertility. The rising prevalence of infertility conditions around the world is set to be the prime driver for the assisted reproductive technology market, as the prevalence of the lifestyle factors contributing to infertility has risen spectacularly over the last few decades.
On the other hand, the risks of assisted reproductive technology and the relatively low chances of success are likely to count against the assisted reproductive technology market over the forecast period. Assisted reproductive treatments are highly expensive, eliminating a large share of the population from availing them, particularly in developing countries. They also carry a risk of premature births and low birth weight in the newborns. The underlying factors responsible for the infertility may also have an effect on the assisted pregnancy, leading to birth defects in the child. Such factors are likely to hold back the assisted reproductive technology market over the forecast period.
Assisted Reproductive Technology Market- Competitive Analysis:
Leading players in the global assisted reproductive technology market include Cosmos Biomedical Limited, Bloom IVF Centre, Parallabs, Anecova, Microm Ltd., Cooper Surgical Inc., European Sperm Bank, Hamilton Throne Ltd., Irvine Scientific, Ferring Pharmaceuticals, Merck KGaA, Origio, OvaScience, Cryolab Ltd., and California Cryobank.
Assisted Reproductive Technology Market- Segmentation:
The global assisted reproductive technology market is segmented by diagnosis, type, end user, and region.
By Diagnosis, the global assisted reproductive technology market is segmented into ovulation testing and hysterosalpingography.
By Type, the assisted reproductive technology market is segmented into ovulation induction, artificial insemination, and surrogacy.
By End-Use, the assisted reproductive technology market is segmented into hospitals & clinics and IVF centers.
Assisted Reproductive Technology Market- Regional Analysis:
On the basis of region, the global assisted reproductive technology market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa.
Europe is expected to remain the leading contributor to the global assisted reproductive technology market over the forecast period due to the relative economic freedom of new mothers in the region, which means they can avail a number of assisted reproductive technologies with ease. The increasing research and innovation in assisted reproductive technologies in Europe is also likely to be a major driver for the assisted reproductive technology market in Europe over the forecast period. The increasing access to infertility treatments in this region is likely to be a major driver for the assisted reproductive technology market in the region.
North America is likely to follow Europe in the global assisted reproductive technology market due to the growing prevalence of infertility in the region. Lifestyle factors contributing to infertility, such as obesity, drinking, and smoking, are highly prevalent among North American men and women, especially in the U.S., leading to a steady growth in the rate of infertility. Obesity, in particular, is rampant among both men and women in North America, leading to a growing prevalence of infertility. This is likely to drive the assisted reproductive technology market in the Americas region over the forecast period.
Asia Pacific is also likely to be a key contributor to the global assisted reproductive technology market over the forecast period due to the growing awareness about fertility treatments. It is expected to emerge as the fastest growing regional market for assisted reproductive technologies over the forecast period.
TABLE OF CONTENT
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
Continued...
LIST OF TABLES
Table 1 Assisted Reproductive Technology (ART) Market Industry Synopsis, 2018–2023
Table 2 Global Assisted Reproductive Technology (ART) Market Estimates & Forecast, 2018–2023, (USD Million)
Table 3 Global Assisted Reproductive Technology (ART) Market, By Region, 2018–2023, (USD Million)
Table 4 Global Assisted Reproductive Technology (ART) Market, By Diagnosis, 2018–2023, (USD Million)
Table 5 Global Assisted Reproductive Technology (ART) Market, By Type, 2018–2023, (USD Million)
Table 6 Global Assisted Reproductive Technology (ART) Market, By End-User, 2018–2023, (USD Million)
Table 7 North America Assisted Reproductive Technology (ART) Market, By Diagnosis, 2018–2023, (USD Million)
Table 8 North America Assisted Reproductive Technology (ART) Market, By Type, 2018–2023, (USD Million)
Table 9 North America Assisted Reproductive Technology (ART) Market, By End-User, 2018–2023, (USD Million)
Table 10 US Assisted Reproductive Technology (ART) Market, By Diagnosis, 2018–2023, (USD Million)
Get More Information on Assisted Reproductive Technology Market  Research Report- Global Forecast to 2023@https://www.marketresearchfuture.com/reports/assisted-reproductive-technology-market-6359
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: , ,

Surgical Lights Market by Application, By Type, by End User and Region

Overview:
Market Research Future (MRFR) in their latest report on the surgical light market revealed a possibility of 4.53% CAGR during the forecast period (2014-2023). Surgical lights are also known as surgical lamps or operating light. These lights are used to assist surgeons during surgical procedures. An effective surgery depends much on proper illumination of the area to avoid any kind of injury to the patient. There are several factors that influence the quality of surgical lights Color Rendering Index (CRI), shadow dilution, brightness, Correlated Color Temperature (CCT), homogeneity, and others.
The major driving factor for the surgical light market is the increasing demand for latest technologies to provide patients best possible care. At the same time, doctors and his associates require maximum assistance to help them perform better. Hence, hospitals and other surgical service providers are installing the best quality products. This can ensure growth for the surgical lights market in the coming years.
Competitive Landscape:
Several players in the global surgical lights market are making substantial changes. They are Technomed India BihlerMED, A-dec Inc., Getinge AB, CV Medical, Hill-Rom Services Inc., Integra LifeSciences Corporation, Medical GmbH & Co. KG, KONINKLIJKE PHILIPS N.V., Herbert Waldmann GmbH & Co. KG, S.I.M.E.O.N. Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Stryker, SKYTRON, STERIS plc, Sunnex Group, and others. These companies get involved in strategic development to take the market forward.
In 2019, Surgiris introduced their surgical lights such as EPURE and DIASYS to the Arabian market to grab the opportunity of having their business expanded in the Middle East region. EPURE has LED control and technologies such as FOCUSMATIC and MOTION MATIC play important role in making it one of the best available in the market.  
Segmental Analysis:
MRFR’s attempt to dig deep into the surgical lights market is based on a segmentation by type, technology, application, and end-users.
Based on the type, the global surgical lights market includes surgical lights and examination lights. The surgical lights segment comprises mobile surgical headlights, surgical lights, ceiling mounted, and wall mounted surgical lights. The examination lights segment is sub-segmented into vein light, endoscopes lights, general exam light, and medical penlight.
By technology, the global surgical lights market is segmented into LED and halogen lights. The LED segment is gaining much prominence due to its durability.
By application, the surgical lights market comprises dental procedures, endoscopy procedures, surgical suites, and others.
Based on the end-user, the global surgical lights market consists hospital operating rooms, ambulatory surgical centers, and procedure rooms. The hospital operating rooms segment is getting much traction due to scope for investment and infrastructure.
Regional Analysis:
MRFR’s take on the global surgical light market includes regions, namely, the America, Europe, Asia Pacific, and the Middle East & Africa (MEA).
The market of the Americas includes a special focus on the LED surgical lights in operating rooms and ambulatory surgical centers. The regional market is primarily getting driven by North America where market giants like the U.S. and Canada are booming due to their superior infrastructure as that facilitates easy incorporation of any new technology. South America could also create substantial demand for the market owing to the betterment in healthcare structure.
Europe’s growth is mostly depending on the number of suppliers in the region. They are providing in the implementation of advanced technology inside the operation theatre. Germany, U.K, and France are contributing the most and it is due to their superior technological backup.
The APAC market is benefitting from the synergistic efforts shown by governments and private organizations. The growing intake of LED lights for a better infrastructural setup is expected to provide the market much-needed support. India, China, and Japan are the largest contributors. This regional growth is getting more thrust due to the burgeoning demand for cost-effective surgical lighting solutions.
In the Middle East & Africa, the market would get substantial traction from countries Saudi Arabia, Qatar, Oman, and Dubai. These regions are investing significantly to take the market forward.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: , , , ,

Thursday, 29 August 2019

Recent research: Cancer Registry Software Market growing at high CAGR by 2024: Size, Share, Analysis, Upcoming Trends

Cancer Registry Software Market Highlights
The global cancer registry software market held a market value of USD 56.4 million in 2019 and is projected to grow at a CAGR of 10.7% over the forecast period.  
Cancer registry software is a disease registry that is mainly used to establish and maintain a cancer incidence reporting system. It acts as an informational resource for the investigation of cancer and its causes. This type of registry software is important as cancer is among the leading causes of death worldwide and therefore the collection of data on cancer cases from diagnosis through survivorship is beneficial to help identify trends and ultimately improve care for patients that are fighting cancer.
However, privacy and data security-related concerns and reluctance to adopt advanced solutions may restrict the growth of the market during the forecast period.
Cancer Registry Software Market Key Players
Some of the prominent players in the global cancer registry software market are Onco, Inc., Rocky Mountain Cancer Data Systems, McKesson Corporation, Elekta AB (PUB), C/Net Solutions, Electronic Registry Systems, Inc., Rocky Mountain Cancer Data Systems, McKesson Corporation, Ordinal Data Inc, Conduent Inc, IBM, Himagine Solutions Inc.
Cancer Registry Software Market Regional Analysis
On a regional basis, the Americas is anticipated to dominate the global cancer registry software market owing to the innovative product development and increasing investment in research and development for innovation in the region.  
Europe is expected to hold the second largest position in the global cancer registry software market owing to the presence of strong academic & research base and availability of funding for research in the European countries.
Asia-Pacific is anticipated to be the fastest growing region in the global cancer registry software market owing to the shift of pharmaceutical companies to countries such as India and China, which are low-cost manufacturing regions.
The Middle East & Africa has the least share of the global cancer registry software market.  Moreover, the major market share of the region is expected to be held by the Middle East region owing to the growing government initiatives for the healthcare sector.
Cancer Registry Software Market Segmentation
The global cancer registry software market has been segmented into type, deployment model, database type, functionality and end user.
By type, the market has been segmented into integrated software and standalone software.
Based on deployment model, the market has been segmented into cloud-based models and on-premise models.
On the basis of database type, the market has been segmented into commercial databases and public databases.
By functionality, the market has been segmented into patient care management, product outcome evaluation, cancer reporting to meet state and federal regulations, medical research & clinical studies.
The market, by end user, has been segmented into hospitals & medical practices, government organizations & research centers, pharmaceutical, biotechnology, and medical device companies, and others.
About Market Research Future: 
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
 Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: , , ,

Monday, 26 August 2019

Anticholinergic Drugs Industry Size, Share, Global Trends, New Drugs Application, Demand And Forecast to 2023

Anticholinergic Drugs Market Report covers a valuable source of perceptive information for business strategists. Anticholinergic Drugs Industry provides the overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elegant description of the value chain and its distributor analysis.

Anticholinergic Drugs Market Highlights
The Global Anticholinergic Drugs Market is expected to register a CAGR of 4.50% during the forecast period with a market value of USD 7,149.90 million till 2024. Anticholinergics drugs are a broad class of drugs that block acetylcholine-mediated neurotransmission in the smooth muscle, heart, central, and peripheral nervous systems. Acetylcholine is a neurotransmitter, or a chemical messenger released by nerve cells to send signals to other cells.


The increasing prevalence of chronic diseases and increasing investments and funding in the field of life science research has led to the growth of the global anticholinergic drugs market in recent years. Moreover, the aging population is expected to fuel market growth. However, side-effects of anticholinergic drugs and stringent regulations are projected to hamper the growth of the market during the assessment period.

Anticholinergic Drugs Market Studied By Top Players
Market Research Future (MRFR) recognizes following companies as key players in the global anticholinergic drugs market that include Pfizer Inc. (US), Allergan Plc (US), Astellas Pharma Inc. (Japan), Johnson & Johnson Services Inc. (US), Teva Pharmaceutical Industries Ltd (Israel), Sanofi (France), GlaxoSmithKline Plc (UK), Boehringer Ingelheim International GmbH (Germany) and others.

Anticholinergic Drugs Market- Segment Analysis
The anticholinergic drugs market, based on product type, has been segmented into synthetic compounds, natural, semi-synthetic compounds. The anticholinergic drugs market, based on application, has been segmented into the overactive bladder, Parkinson’s disease, chronic obstructive pulmonary disease, muscle spasms, irritable bowel syndrome. On the basis of route of administration, the market is segmented into oral, parenteral, topical. On the basis of end user, the market is segmented into hospitals and pharmacies.

 Regional Analysis
The Global Anticholinergic Drugs Market, based on region, is divided into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.
The Americas is expected to hold the largest share of the global anticholinergic drugs market. This owes to the rising geriatric population along with the high prevalence of CNS diseases and demand for effective therapies. The Europe market demonstrated substantial growth in the market due to the rising prevalence of bladder overactivity, increasing geriatric population, and rising healthcare expenditure. Germany held a share of 25.8% in the Western Europe anticholinergic drugs market in 2018. Asia-Pacific is estimated to be the fastest growing region in the global market due to the presence of a large number of research organizations and development of new infrastructure to support the healthcare industry. Also, the Middle East and Africa region is expected to show the least growth owing to low per capita income and lack of adequate healthcare spending.
Key Findings of the Study
  • The Global Anticholinergic Drugs Market is projected to reach USD 7,149.90 Million by 2024 at a CAGR of 4.50% during the review period from 2019 to 2024.
  • Americas accounted for the largest share of the global market due to the high prevalence of CNS diseases and demand for effective therapies.
  • The overactive bladder application segment accounted for the largest market share of 4% in 2018.
 List Of Table
Table 1 List Of Assumptions 15 
Table 2 Global Anticholinergic Drugs Market, By Type 2016-2024 (Usd Million) 32 
Table 3 Global Anticholinergic Drugs Market For Synthetic Compounds, By Region, 2016–2024 (Usd Million) 32 
Table 4 Global Anticholinergic Drugs Market For Natural, By Region, 2016–2024 (Usd Million) 33 
Table 5 Global Anticholinergic Drugs Market For Semi-Synthetic Compounds, By Region, 2016–2024 (Usd Million) 33
Table 6 Global Anticholinergic Drugs Market, By Application 2016-2024 (Usd Million) 36 
Table 7 Global Anticholinergic Drugs Market For Overactive Bladder, By Region, 2016–2024 (Usd Million) 36 
Table 8 Global Anticholinergic Drugs Market For Parkinson’s Disease, By Region, 2016–2024 (Usd Million) 37 
Table 9 Global Anticholinergic Drugs Market For Chronic Obstructive Pulmonary Disease (Copd), By Region, 
2016–2024 (Usd Million) 37 
Table 10 Global Anticholinergic Drugs Market For Muscle Spasms, By Region, 2016–2024 (Usd Million) 38 

Trending Reports



 About Market Research Future: 
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: , , ,
Subscribe to: Posts (Atom)